| The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms JD Khoury, E Solary, O Abla, Y Akkari, R Alaggio, JF Apperley, R Bejar, ... leukemia 36 (7), 1703-1719, 2022 | 1707 | 2022 |
| Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML) N Patkar, C Kakirde, AF Shaikh, R Salve, P Bhanshe, G Chatterjee, ... Leukemia 35 (5), 1392-1404, 2021 | 64 | 2021 |
| Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase … PR Tembhare, S Ghogale, N Ghatwai, Y Badrinath, N Kunder, NV Patkar, ... Cytometry Part B: Clinical Cytometry 94 (1), 100-111, 2018 | 59 | 2018 |
| A high‐sensitivity 10‐color flow cytometric minimal residual disease assay in B‐lymphoblastic leukemia/lymphoma can easily achieve the sensitivity of 2‐in‐106 and is superior … PR Tembhare, PG Subramanian PG, S Ghogale, G Chatterjee, NV Patkar, ... Cytometry Part B: Clinical Cytometry 98 (1), 57-67, 2020 | 58 | 2020 |
| Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country N Patkar, AA Alex, R Ahmed, A Abraham, B George, A Vishwabandya, ... Cytometry Part B: Clinical Cytometry 82 (4), 252-258, 2012 | 53 | 2012 |
| Immunoprofile of Hodgkin's lymphoma in India N Patkar, J Mehta, B Kulkarni, R Pande, S Advani, A Borges Indian journal of cancer 45 (2), 59-63, 2008 | 40 | 2008 |
| Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable … PR Tembhare, H Sriram, T Khanka, G Chatterjee, D Panda, S Ghogale, ... Journal for Immunotherapy of Cancer 8 (1), 2020 | 35 | 2020 |
| Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia N Patkar, R Kodgule, C Kakirde, G Raval, P Bhanshe, S Joshi, ... Oncotarget 9 (93), 36613, 2018 | 34 | 2018 |
| A novel and easy F xCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six‐color immunophenotyping P Tembhare, Y Badrinath, S Ghogale, N Patkar, N Dhole, P Dalavi, ... Cytometry Part A 89 (3), 281-291, 2016 | 34 | 2016 |
| Mandatory preoperative COVID‐19 testing for cancer patients—Is it justified? SS Nekkanti, S Vasudevan Nair, V Parmar, A Saklani, S Shrikhande, ... Journal of Surgical Oncology 122 (7), 1288-1292, 2020 | 32 | 2020 |
| A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2 B Dharavath, N Yadav, S Desai, R Sunder, R Mishra, M Ketkar, ... Heliyon 6 (7), 2020 | 32 | 2020 |
| Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol A Rajendra, H Jain, VNA Bonda, L Nayak, P Tembhare, D Shetty, J Thorat, ... Blood advances 5 (5), 1178-1193, 2021 | 25 | 2021 |
| Infection prevalence in adolescents and adults with acute myeloid leukemia treated in an Indian tertiary care center H Jain, K Rengaraj, V Sharma, A Bonda, R Chanana, J Thorat, A Ronghe, ... JCO Global Oncology 6, 1684-1695, 2020 | 24 | 2020 |
| MYD88 mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart N Patkar, PG Subramanian, P Deshpande, K Ghodke, P Tembhare, ... Leukemia & lymphoma 56 (2), 420-425, 2015 | 24 | 2015 |
| SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study S Dhumal, A Patil, A More, S Kamtalwar, A Joshi, A Gokarn, S Mirgh, ... International Journal of Infectious Diseases 118, 95-103, 2022 | 23 | 2022 |
| Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also … N Patkar, K Ghodke, S Joshi, S Chaudhary, R Mascerhenas, S Dusseja, ... Leukemia & lymphoma 57 (11), 2653-2660, 2016 | 22 | 2016 |
| Report of proceedings of the national meeting on" Guidelines for Immunophenotyping of Hematolymphoid Neoplasms by Flow Cytometry" S Gujral, PG Subramanian, N Patkar, Y Badrinath, A Kumar, P Tembhare, ... Indian Journal of Pathology and Microbiology 51 (2), 161-166, 2008 | 22 | 2008 |
| Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context N Patkar, C Kakirde, P Bhanshe, S Joshi, S Chaudhary, Y Badrinath, ... Frontiers in Oncology 9, 450, 2019 | 20 | 2019 |
| Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India N Rabade, PG Subramanian, R Kodgule, G Raval, S Joshi, S Chaudhary, ... Indian Journal of Pathology and Microbiology 61 (2), 209-213, 2018 | 20 | 2018 |
| CD19 negative precursor B acute lymphoblastic leukemia (B‐ALL)—immunophenotypic challenges in diagnosis and monitoring: a study of three cases K Ghodke, A Bibi, N Rabade, N Patkar, PG Subramanian, PA Kadam, ... Cytometry Part B: Clinical Cytometry 92 (4), 315-318, 2017 | 20 | 2017 |
